TY - JOUR T1 - Serogroup B meningococcal disease during Hajj: preparing for the worst scenario. AU - Khalil,Mohamed K M, AU - Borrow,Ray, Y1 - 2009/08/11/ PY - 2009/07/07/received PY - 2009/07/14/revised PY - 2009/07/16/accepted PY - 2009/9/1/entrez PY - 2009/9/1/pubmed PY - 2009/12/23/medline SP - 231 EP - 4 JF - Travel medicine and infectious disease JO - Travel Med Infect Dis VL - 7 IS - 4 N2 - The Islamic Hajj pilgrimage to Mecca, Saudi Arabia has historically been associated with outbreaks of serogroup A and W135 meningococcal disease. Prevention against meningococcal disease has principally been vaccination with meningococcal polysaccharide vaccines, either in a bivalent serogroup A/C or quadrivalent A/C/Y/W135 form. These interventions have suppressed meningococcal disease since 2002. Countries with large Muslim populations have now started to show a trend of increased serogroup B meningococcal disease, a serogroup for which there is no universal vaccine available. These trends should increase our preparedness to expect a sudden change in the etiology of meningococcal disease during the Hajj. SN - 1873-0442 UR - https://www.unboundmedicine.com/medline/citation/19717106/Serogroup_B_meningococcal_disease_during_Hajj:_preparing_for_the_worst_scenario_ DB - PRIME DP - Unbound Medicine ER -